Affinia TherapeuticsListed
No domain yetbiotech_life_sciences
Biotechnology company developing rationally designed AAV gene therapies for cardiovascular and neurological diseases. Its proprietary ART platform uses AI and structural modeling…
Portfolio
A closer look at the companies associated with this firm. Verified team members can update the portfolio after signing in.
This is the portfolio currently shown on the public firm page.
Biotechnology company developing rationally designed AAV gene therapies for cardiovascular and neurological diseases. Its proprietary ART platform uses AI and structural modeling…
Abcuro is developing breakthrough therapies for autoimmune diseases and cancer, focusing on selective targeting of highly cytotoxic T cells. Their lead product candidate, ulviprub…
Clinical-stage biotechnology company developing CAR-TEAM, an autologous T-cell immunotherapy platform that combines CAR-T cells with secreted bispecific T-cell-engaging antibody m…
Biotech company developing therapeutics that harness the immune system to treat major autoimmune diseases with limited treatment options. Its approach targets signaling between T…
Biotechnology company translating discoveries into novel therapies for Friedreich’s ataxia, targeting a key driver of cellular dysfunction.
Harbor Health, formerly known as Village Medical, provides comprehensive healthcare services including primary care and health insurance plans designed by doctors to enhance patie…
Mediar Therapeutics is pioneering a novel approach to fibrosis treatment by disabling the myofibroblast, the key pathogenic cell in fibrosis that drives scarring, disease progress…
Stealth-stage biotechnology company discovering and developing targeted therapies for serious and rare diseases by leveraging TGF-beta superfamily biology. The company focuses on…
InStride Health provides specialty outpatient care focused on pediatric anxiety and OCD treatment for children and young adults aged 7-22. Their evidence-based approach includes i…
We are delivering transformative therapies by harnessing the potential of covalent medicines and chemical proteomics coupled with deep human translational insights.
Nocion Therapeutics is a biopharmaceutical company developing 'nocions'—a new kind of therapy that selectively affects actively firing nociceptors to provide targeted relief for c…
A proximity-based therapeutics biotech developing targeted protein modulation medicines using proprietary PHICS and tPRIME platforms and PROTAC expertise. Its pipeline targets aut…
Develops a molecular insights and diagnostic platform for blood cancers, using whole-genome sequencing of circulating tumor cells from blood or bone marrow samples and single-cell…
Clinical-stage medical technology company developing biodegradable polymers for unmet needs in vitreoretinal surgery. Its lead investigational product, PYK-2101, is an in situ cro…
QurAlis is a biotech company developing precision medicines for ALS and other neurological diseases.
A value-based palliative care provider group supporting people with serious illness and their caregivers. Multidisciplinary clinical teams deliver symptom management, emotional su…
Clinical-stage biotechnology company developing disease-modifying medicines for rare and other proteinuric chronic kidney diseases. Its pipeline includes WAL0921, a humanized mono…
California-based biopharmaceutical company founded in 2003, focused on developing therapeutics. Its pipeline included RG-6125, a CDH11 inhibitor associated with neoplasms; Roche a…
Details are not available yet. The company remains listed.
Develops and produces etomidate-based anesthetic products designed not to affect breathing and blood pressure in the way other anesthetics may. Markets its products to anesthesiol…
CoStim Pharmaceuticals is focused on developing breakthrough biotechnology solutions, particularly in the field of cancer treatment through immune checkpoint modulation.
Medical evidence network providing access to points of care and curated clinical and imaging data, with technology for sharing and managing medical imaging and information.
Biotechnology company developing therapies for neurodegenerative diseases, with a focus on GBA-associated parkinsonism. Its lead drug candidate, LTI-291, targets disease biology l…
QPID Health is a healthcare technology company that specializes in advanced analytics and clinical reasoning platforms, utilizing natural language processing (NLP) and machine lea…
Scorpion provides revenue-focused digital marketing solutions and technology for local businesses and multi-location organizations. Its services include website design, SEO, paid…
SEQURE (Guangdong Sequre Technology Co., Ltd.) is a technology company that researches, designs, manufactures, and sells electronics and DIY tools. Its products include mini smart…
Clinical-stage biotechnology company developing antibody therapeutics targeting the neonatal Fc receptor (FcRn) for IgG-mediated autoimmune diseases. Its lead candidate, SYNT001,…
Biotechnology company developing anti-LAP monoclonal antibodies that target the latent TGF-beta complex and modulate regulatory T-cell-mediated immune suppression. Its immuno-onco…
Verve Therapeutics is a cardiovascular gene editing company focused on developing groundbreaking, single-course gene editing medicines to combat cardiovascular disease.
Biotechnology company developing precision genetic therapies intended to restore, improve, and preserve hearing, including treatments targeting hearing loss through inner-ear gene…
Denali Therapeutics is focused on developing therapies for neurodegenerative diseases using their proprietary TransportVehicle™ platform.
Editas Medicine is a pioneering gene editing company focused on developing transformative medicines using CRISPR technology to treat serious diseases.
Keros is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematological, pulm…
Clinical-stage biotechnology company developing medicines to make the curative potential of stem cell transplantation available to more patients with blood cancers, genetic diseas…
Spero Therapeutics is a clinical-stage biopharmaceutical company advancing innovative medicines for immune-mediated diseases, beginning with SP001, a third-generation anti-CD40L a…
Details are not available yet. The company remains listed.
A pharmaceutical biotechnology company developing next-generation targeted protein degraders for neurodegenerative diseases. Its lead program is an oral, brain-penetrant degrader…
Claris Bio is a late-stage therapeutics company dedicated to advancing transformative therapies for sight-threatening conditions where no or limited treatment options exist.
Violet Therapeutics is a pre-clinical stage company leveraging a first-in-class platform to identify, map and mine cell-to-cell communication at scale. Violet’s drug discovery pro…